Resumo
Definición
Anamnesis y examen
Principales factores de diagnóstico
- urethral discharge in men
- tenderness and/or swelling of the epididymis
- mucopurulent or purulent exudate at the endocervix
Otros factores de diagnóstico
- pelvic pain in women
- urethral irritation in men
- dysuria in men
- tenderness and/or swelling of testis
- tenderness and/or swelling of prostate
- anal pruritus
- mucopurulent discharge from the rectum
- rectal pain
- tenesmus
- rectal bleeding
- vaginal discharge
- cervical friability
- uterine, adnexal, or cervical motion tenderness
- uterine mass
- anterior cervical lymphadenopathy
- conjunctivitis
- fever
- skin lesions (papules, bullae, petechiae, or necrotic) at extremities
- polyarthritis
- purpuric rash
- positive Brudzinski and Kernig sign
- seizures
- focal cerebral signs
- murmur
- ophthalmia neonatorum
- rhinitis
- urethritis (infantile)
- vaginitis
Factores de riesgo
- age 20 to 24 years
- men who have sex with men (MSM)
- black ancestry
- current or prior history of STI
- multiple recent sex partners
- inconsistent condom use
- risk factors of partner
- history of sexual or physical abuse
- substance use
- past incarceration
- high-morbidity community
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- nucleic acid amplification test (NAAT)
- culture
- urinalysis in men
- Gram stain of urine sediment
- Gram stain of urethral discharge
- HIV test
- syphilis test
Pruebas diagnósticas que deben considerarse
- transvaginal ultrasound
- pelvic CT/MRI
Algoritmo de tratamiento
nonpregnant >45 kg: urogenital/anorectal or pharyngeal infection (excluding complicated genitourinary infection)
nonpregnant >45 kg: complicated genitourinary infection
nonpregnant >45 kg: disseminated gonococcal infection
pregnant: uncomplicated urogenital/anorectal or pharyngeal infection (excluding complicated genitourinary infection)
pregnant: complicated infection
neonate
child ≤45 kg
recurrent/resistant: urogenital/anorectal infection or pharyngitis
Colaboradores
Autores
Sheldon Morris, MD, MPH
Assistant Professor
Division of Infectious Diseases
Department of Medicine
UCSD Antiviral Research Center
Division of Family Medicine
Department of Family and Preventive Medicine
UCSD La Jolla Family and Sports Medicine
San Diego
CA
Divulgaciones
SM has received research funding via his institution from Merck, Gilead Sciences, National Institutes of Health, California HIV/AIDS Research Program, and California Institute for Regenerative Medicine. He has completed a National Institutes of Health contract for research study on the Visby Medical Sexual Health Test. He holds stock in Bristol Myers Squibb and Pfizer. He is a co-founder of Aspera Biomedicines and a consultant for Primmune Therapeutics. SM is an author of a number of references cited in this topic.
Revisores por pares
Vani Dandolu, MD, MPH
Associate Professor
Ob/Gyn and Urology
Director
Division of Urogynecology
Associate Residency Program Director
Temple University Hospital
Philadelphia
PA
Divulgaciones
VD declares that he has no competing interests.
Eva Jungmann, FRCP MSc
Consultant in Genitourinary and HIV Medicine
Archway Centre & Mortimer Market Centre
London
UK
Divulgaciones
EJ declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Centers for Disease Control and Prevention. Gonococcal isolate surveillance project (GISP). 30 August 2021 [internet publication].Texto completo
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Texto completo Resumen
Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004 May 12;291(18):2229-36.Texto completo Resumen
Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014;63(RR-02):1-19.Texto completo Resumen
Fifer H, Saunders J, Soni S, et al. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae. Int J STD AIDS. 2020 Jan;31(1):4-15.Texto completo Resumen
US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. JAMA. 2021 Sep 14;326(10):949-56.Texto completo Resumen
World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae. 2016 [internet publication].Texto completo
Centers for Disease Control and Prevention. Guidance on the use of expedited partner therapy in the treatment of gonorrhea. 18 August 2021 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Chlamydia infection
- Trichomonas
- Other infectious causes of urethritis, cervicitis, pelvic inflammatory disease (PID), and epididymitis
Más DiferencialesGuías de práctica clínica
- Reducing sexually transmitted infections
- Guidance on the use of expedited partner therapy in the treatment of gonorrhea
Más Guías de práctica clínicaFolletos para el paciente
Gonorrhea
Más Folletos para el pacienteVideos
Intramuscular injection animated demonstration
Más vídeosInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad